We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Exploiting the Biophysical "Sweet Spot" in Fragment Screening


Exploiting the Biophysical "Sweet Spot" in Fragment Screening

Pharmaceutical companies are increasingly under pressure to reduce the time it takes to discover new medicines. Recent advances in biophysical screening technology have made the detection of binding events associated with the smallest of fragments possible.

Often the biological target of interest has been determined but the identification of a suitable chemical starting point to optimize and deliver a drug candidate can often slow down the discovery process.

Watch this webinar to learn more about:

  • Optimal fragment library design 
  • Biophysical screening and how it can be used to identify novel hits
  • A cost-effective and expedient assay methodology
  • How to speed up the timeline from target identification to confirmed hit from months (HTS), to weeks (fragment library)


Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free